Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sai Parenteral'sNSE:SAIPARENT +5.28%14 Days Inventory is 162.09 as of Sep. 2025, which is 67% above its 10-year median of 96.85. GuruFocus rates NSE:SAIPARENT with a GF Score™ of 14/100. The stock has 7 warning signs investors should review. Among 921 Drug Manufacturers companies, Sai Parenteral's ranks worse than 87.08% on this metric.
The historical rank and industry rank for Sai Parenteral's's Days Inventory or its related term are showing as below:
NSE:SAIPARENT'
s Days Inventory Range Over the Past 10 Years
Min: 83.06 Med: 96.85 Max: 324.18
Current: 324.18
During the past 3 years, Sai Parenteral's's highest Days Inventory was 324.18. The lowest was 83.06. And the median was 96.85.
NSE:SAIPARENT's Days Inventory is ranked worse than 87.08% of 921
companies
in the Drug Manufacturers industry
Industry Median: 165.24
vs NSE:SAIPARENT: 324.18
Sai Parenteral's's Days Inventory
increased
from Mar. 2024 (0.00) to Sep. 2025 (162.09).
It might indicate that Sai Parenteral's's sales slowed down.
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Sai Parenteral's's Inventory Turnover for the
six
months ended in Sep. 2025 was 1.13.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Sai Parenteral's's Inventory-to-Revenue for the
six
months ended in Sep. 2025 was 0.52.
Sai Parenteral's (NSE:SAIPARENT) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Sai Parenteral's's Inventory Turnover for the
six
months ended in Sep. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Sai Parenteral's's Inventory to Revenue for the
six
months ended in Sep. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Sai Parenteral's Days Inventory Related Terms
Sai Parenteral's Days Inventory Historical Data
* Premium members only.
The historical data trend for Sai Parenteral's's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sai Parenteral's Days Inventory Chart
Sai Parenteral's Annual Data
Trend
Mar23
Mar24
Mar25
Days Inventory
83.06
96.85
127.31
Sai Parenteral's Semi-Annual Data
Mar23
Mar24
Mar25
Sep25
Days Inventory
0.00
0.00
0.00
162.09
NSE:SAIPARENT vs LLY, JNJ, ABBV: Days Inventory Comparison
For the Drug Manufacturers - General subindustry, Sai Parenteral's's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sai Parenteral's Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sai Parenteral's's Days Inventory distribution charts can be found below:
* The bar in red indicates where Sai Parenteral's's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sai Parenteral's (NSE:SAIPARENT) has a Days Inventory of 162.09 as of Sep. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Sai Parenteral's and its competitors. This is 67% above median its historical median of 96.85. Over the past decade, Sai Parenteral's' Days Inventory has ranged from 83.06 to 324.18. According to the industry distribution chart, Sai Parenteral's ranks #802 out of 921 companies in the Drug Manufacturers industry, placing it in the top 87.1%.
Is Sai Parenteral's' Days Inventory too high?
Sai Parenteral's' current Days Inventory of 162.09 is 67% above median its 10-year median of 96.85. Over the past 10 years, this metric has ranged from a low of 83.06 to a high of 324.18. The Drug Manufacturers industry median Days Inventory is 165.24. Sai Parenteral's' value of 162.09 is 1.9% below this industry median. Based on the distribution chart, Sai Parenteral's ranks #802 out of 921 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Sai Parenteral's has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Sai Parenteral's' Days Inventory compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Sai Parenteral's ranks #802 out of 921 companies for Days Inventory. This places Sai Parenteral's in the lower half of its industry. The industry median Days Inventory is 165.24. Sai Parenteral's' value of 162.09 is 1.9% below this benchmark. Historically, Sai Parenteral's' own Days Inventory has ranged from 83.06 to 324.18 over the past decade. While the company's 10-year median is 96.85 vs. the industry median of 165.24, Sai Parenteral's has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 165.24, based on 921 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sai Parenteral's's current Days Inventory of 162.09 is 1.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Sai Parenteral's and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 165.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sai Parenteral's's current Days Inventory is 162.09, which is 67% above median its own 10-year median of 96.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sai Parenteral's stock overvalued right now?
Sai Parenteral's (NSE:SAIPARENT) has a current Days Inventory of 162.09. The current Days Inventory is 162.09, which is 67% above median its 10-year median of 96.85 and 1.9% below the Drug Manufacturers industry median of 165.24. Sai Parenteral's' overall GF Score™ is 14/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Sai Parenteral's (NSE:SAIPARENT), the current Days Inventory is 162.09 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sai Parenteral's Ltd is a diversified pharmaceutical formulations company. Its business is organised in two verticals: (i) Branded Generic Formulations: Through the branded generics portfolio, it serves the domestic market with formulations across multiple therapeutic areas. and (ii) Contract Development and Manufacturing Organisation (CDMO): It provides CDMO services to pharmaceutical companies, supporting activities from product development to commercial manufacturing. Its product portfolio includes cardiovascular care, neuropsychiatry, anti-diabetic therapy, respiratory health, antibiotics, gastroenterology, vitamins, etc. The majority of the company's revenue is derived from the Branded Generic Formulations business.
14GF Score
Get the complete analysis for NSE:SAIPARENT
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SAIPARENT has been successfully added to your 
